Materias dentro de su búsqueda.
Mostrando 881 - 900 Resultados de 58,773 Para Buscar '"Her"', tiempo de consulta: 0.25s Limitar resultados
  1. 881
    “…Examination of parity, age at menarche and at menopause by HER2 status in a large series of breast carcinomas showed a statistically significant increased-frequency of HER2-positive tumours in lower risk subgroups. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Role of hormonal risk factors in HER2-positive breast carcinomas
  2. 882
    Enlace del recurso
    Enlace del recurso
    Texto
    Luminal B breast tumors are not HER2 positive – authors' response
  3. 883
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Freund's vaccine adjuvant promotes Her2/Neu breast cancer
  4. 884
    “…Using the ongoing neoadjuvant trials with HER2 (human epidermal growth factor receptor 2)-directed therapy as a paradigm, this article discusses recent innovations in study design and the challenges of conducting translational research in the neoadjuvant setting.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
  5. 885
    “…This paper provides a historical and current perspective of the treatment of patients with HER2-positive breast cancer.…”
    Enlace del recurso
    Enlace del recurso
    Texto
    Targeting HER2 in breast cancer: overview of long-term experience
  6. 886
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Texto
    Oculo-facio-cardio-dental syndrome in a girl and her mother
  7. 887
    por Abdel-Razeq, Hikmat, Marei, Lina
    Publicado 2011
    “…With the recent introduction of new anti-HER2 drugs, interest has shifted toward dual HER2 blockade. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current neoadjuvant treatment options for HER2-positive breast cancer
  8. 888
    “…The optical redox ratio (fluorescence intensity of NADH divided by that of FAD), was acquired for a panel of breast cancer cell lines to investigate how overexpression of human epidermal growth factor receptor 2 (HER2) affects tumor cell metabolism, and how tumor metabolism may be altered in response to clinically used HER2-targeted therapies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Optical imaging of metabolism in HER2 overexpressing breast cancer cells
  9. 889
    “…The epidermal growth factor receptor 2 (HER2) is a tyrosine kinase overexpressed in nearly 20% to 25% of invasive breast cancers. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Molecular Mechanisms of Trastuzumab Resistance in HER2 Overexpressing Breast Cancer
  10. 890
    por Mukohara, Toru
    Publicado 2011
    “…Approximately 20% of breast cancers overexpress human epidermal growth factor receptor 2 (HER2) protein, mainly as a result of gene amplification. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Role of HER2-Targeted Agents in Adjuvant Treatment for Breast Cancer
  11. 891
    “…BACKGROUND: The frequency of over-expression of human epidermal growth factor receptor-2 (HER-2) in bladder cancer is one of the highest among all human malignancies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Over-expression of HER-2 is associated with the stage in carcinomas of the urinary bladder
  12. 892
    por Gogineni, Keerthi, DeMichele, Angela
    Publicado 2012
    “…So-called 'triple-negative' breast cancer - lacking ER, PR, and Her2 overexpression - remains a major challenge. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Current approaches to the management of Her2-negative metastatic breast cancer
  13. 893
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
  14. 894
    “…A quantitative phosphorylation mapping of HER2 indicated that the agonistic isomers produced a distinct phosphorylation pattern associated with activation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reorienting the Fab Domains of Trastuzumab Results in Potent HER2 Activators
  15. 895
    “…It shows that many factors influence the determination of HER2-expression, especially of the intracellular fraction of HER2. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Cytoplasmic Overexpression of HER2: a Key Factor in Colorectal Cancer
  16. 896
    “…We have synthesized 15/16-mer PNA probes to detect the HER2 mRNA. The performance of these probes to detect the HER2 target was evaluated by fluorescence imaging and fluorescence bead assays. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Development of Peptide Nucleic Acid Probes for Detection of the HER2 Oncogene
  17. 897
    “…PURPOSE: Trastuzumab and chemotherapy is the current standard of care in HER2+ early or locally advanced breast cancer, but there are scanty literature data of its real world effectiveness. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer
  18. 898
    “…BACKGROUND: Her2 expression and amplification occurs in a significant subset of gastro-esophageal carcinomas. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Association between HSP90 and Her2 in Gastric and Gastroesophageal Carcinomas
  19. 899
    “…This manuscript examines inter-scanner and inter-algorithm variability in the assessment of the commonly used HER2/neu tissue-based biomarker for breast cancer with emphasis on the effect of algorithm training. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reproducibility in the automated quantitative assessment of HER2/neu for breast cancer
  20. 900
    “…INTRODUCTION: The presence of HER-2 has been shown to be a prognostic factor in many kinds of cancers, but its role in head and neck squamous cell carcinoma (HNSCC) is not still defined. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Soluble HER-2 in Patients with Head and Neck Squamous Cell Carcinoma
Herramientas de búsqueda: RSS